Revenue
2024
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | — | $217 | — | — |
| Research & development | $231,593 | $165,621 | $411,014 | $113,245 |
| Operating expenses | $1.8M | $1.3M | $1.4M | — |
| Operating income | −$1.8M | −$1.3M | −$1.4M | $560,505 |
| Net income | −$2.2M | −$3.0M | −$2.5M | −$965,150 |
| Basic EPSper diluted share | -$0.01 | -$0.02 | -$0.01 | — |
| Diluted EPSper diluted share | -$0.01 | -$0.02 | -$0.01 | — |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 29, 2026Form 4 | HAUSMAN MARVIN S MDTenPercentOwner | Sellcommon stock | 500.0K | $0.02 | $10.0K | 37.76M |
| Apr 20, 2026Form 4 | HAUSMAN MARVIN S MDTenPercentOwner | Sellcommon stock | 1.50M | $0.02 | $30.0K | 38.26M |